{
  "query": "Alzheimer",
  "resolved": null,
  "signals": [
    {
      "type": "hot_area",
      "headline": "\"Alzheimer\" heating up — 11 grants ($323,634,614), 35 active trials (11 started <12 mo)",
      "entity": "Alzheimer",
      "ticker": null,
      "upstream": {
        "event": "NIH grant velocity",
        "detail": "11 grants, $323,634,614 in window"
      },
      "observed": {
        "event": "Trial velocity",
        "detail": "35 trials, 11 newly started"
      },
      "predicted": {
        "event": "Elevated M&A / licensing / IPO activity in this mechanism over 12–24 mo",
        "leadTime": "12–24 mo",
        "note": "Funding+trial co-velocity historically precedes BD activity; directional only."
      },
      "leadTime": "12–24 mo to BD/commercial activity (directional)",
      "confidence": 0.5,
      "sponsors": [
        "University of Minnesota",
        "National Institute on Aging (NIA)",
        "Bristol-Myers Squibb",
        "National Institute of Mental Health (NIMH)",
        "Fondation Ophtalmologique Adolphe de Rothschild",
        "Northwestern University",
        "University of Wisconsin, Madison",
        "Istituti Clinici Scientifici Maugeri SpA"
      ]
    }
  ],
  "recentFilings": null,
  "disclaimer": "Research/informational. NOT investment advice.",
  "generatedAt": "2026-11-03T09:00:20.748Z"
}